- Home
- DIBS vs ENTA Comparison
DIBS vs ENTA Comparison
Compare DIBS & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DIBS
- ENTA
- Stock Information
- Founded
- DIBS 2000
- ENTA 1995
- Country
- DIBS United States
- ENTA United States
- Employees
- DIBS N/A
- ENTA N/A
- Industry
- DIBS Catalog/Specialty Distribution
- ENTA Biotechnology: Pharmaceutical Preparations
- Sector
- DIBS Consumer Discretionary
- ENTA Health Care
- Exchange
- DIBS Nasdaq
- ENTA Nasdaq
- Market Cap
- DIBS 132.5M
- ENTA 152.3M
- IPO Year
- DIBS 2021
- ENTA 2013
- Fundamental
- Price
- DIBS $4.05
- ENTA $8.13
- Analyst Decision
- DIBS Buy
- ENTA Buy
- Analyst Count
- DIBS 2
- ENTA 4
- Target Price
- DIBS $8.00
- ENTA $17.25
- AVG Volume (30 Days)
- DIBS 77.9K
- ENTA 507.8K
- Earning Date
- DIBS 02-28-2025
- ENTA 02-10-2025
- Dividend Yield
- DIBS N/A
- ENTA N/A
- EPS Growth
- DIBS N/A
- ENTA N/A
- EPS
- DIBS N/A
- ENTA N/A
- Revenue
- DIBS $86,409,000.00
- ENTA $66,590,999.00
- Revenue This Year
- DIBS $5.17
- ENTA N/A
- Revenue Next Year
- DIBS $7.90
- ENTA N/A
- P/E Ratio
- DIBS N/A
- ENTA N/A
- Revenue Growth
- DIBS N/A
- ENTA N/A
- 52 Week Low
- DIBS $3.37
- ENTA $4.71
- 52 Week High
- DIBS $6.30
- ENTA $17.80
- Technical
- Relative Strength Index (RSI)
- DIBS 57.88
- ENTA 77.82
- Support Level
- DIBS $3.99
- ENTA $6.92
- Resistance Level
- DIBS $4.25
- ENTA $8.76
- Average True Range (ATR)
- DIBS 0.13
- ENTA 0.60
- MACD
- DIBS -0.00
- ENTA 0.42
- Stochastic Oscillator
- DIBS 50.00
- ENTA 93.05
About DIBS 1stdibs.com Inc.
1stdibs.com Inc is an online marketplace for connecting design lovers with the sellers and makers of vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The company's single reportable and operating segment contains two reporting units; 1stDibs, which consists of the company's online marketplace that enables commerce between sellers and buyers; and Design Manager, which is the company's separate online platform that is used to sell a software solution to interior designers. It generates revenue primarily from fees from seller marketplace services as well as other services, including advertisements and software services.
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.